PCK

7.14%

3.0¢ painchek ltd

PainChek General Discussion, page-17191

First 17191 Last

Share
Profile

Follow
Ras2

680 Posts.

67

02/09/20

18:24

Post #: 47032673
Share

Originally posted by DoubleDown!: ↑

You'd have to think that PainChek at about these prices is good value. It dropped in to the sixes in March at the bottom of the CoVid crash and we're six months on from there. Maybe it will get there again, but I really don't think so, 8c possibly, 7c would be a steal.

For those holding I imagine most are probably in the red now, and anyone in the green have watched their gains go from up 1000% back to double digits. But the questions now are how will the company go compared to others in the market? Are you prepared to bail at the low point?

The next six months should be good for PainChek. FDA will happen. PainFaces will get clinical validation. DTC will be trialed successfully. Philips will sign a formal agreement. Another 30-50k beds will be activated and I estimate the same will be contracted.

In another thread people are predicting share prices in the $1+ range by June next year. No way. No how. PainChek has lost its darling status, never be returned. The promise and hype from 2018 is gone, replaced by the cold reality that PainChek is useful not a game changer and aged care have very limited funds and roll out is way harder than you'd think. International expansion has provided more or less nothing in the last year, platitudes at best from NZ, SG and the UK. We will get some traction in the next six months to a year but not heaps. I predict less than 50k beds from internationals in the next year.

For those expecting tens of millions from Philips, nuh-uh. The first agreements will be small and targeted, maybe not even material in terms of revenues. But probably around $1-2m on an annual basis, just to start with.

In terms of revenue generation by June next year I don't expect us to be much more than $6-7m, including the government grant. This would price us reasonably around 10c (~$100m).

But those things I listed earlier once achieved give rise to plenty of speculation on future business and that is what will drive the price. 30c could be achievable by June next year.

From 9c to 30c would be a pretty cracking return in nine months I think. Particularly given there is so little risk involved, I just can't see this being 5c in June next year. So much upside at this price, so little downside.

Expand

“The next six months should be good for PainChek. FDA will happen. PainFaces will get clinical validation. DTC will be trialed successfully. Philips will sign a formal agreement. Another 30-50k beds will be activated and I estimate the same will be contracted.”

It needs to be remembered that while the above are upsides, they are also potential downsides. If any of these are a miss, the SP will be slammed. FDA approval is not a given.

PCK Price at posting: 9.2¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MDI

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

SKS

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

AII

Almonty locks in govt agreement for tungsten oxide plant in South Korea

I88

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

NIM

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

IMM

Immutep reports strong response rate from immunotherapies treating carcinomas

Bitcoin investors need to know the risks

BHP

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

There are more pages in this discussion • 3,222 more messages in this thread...

First 17191 Last

Add PCK (ASX) to my watchlist

(20min delay)
Last 3.0¢		Change 0.002(7.14%)		Mkt cap ! $49.07M

Open	High	Low	Value	Volume
2.8¢	3.0¢	2.8¢	$9.306K	318.7K

Buyers (Bids)

No.	Vol.	Price($)
1	43275	2.9¢

Sellers (Offers)

Price($)	Vol.	No.
3.0¢	1255935	2

View Market Depth

No.	Vol.	Price($)
1	43275	0.029
5	1354635	0.028
8	1053639	0.027
3	365422	0.026
3	3000000	0.025

Price($)	Vol.	No.
0.030	1255935	2
0.032	24900	1
0.033	410208	3
0.034	5874	1
0.035	40000	1

Last trade - 16.10pm 12/07/2024 (20 minute delay)

PCK (ASX) Chart

PainChek General Discussion, page-17191

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Immutep reports strong response rate from immunotherapies treating carcinomas

Bitcoin investors need to know the risks

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

PainChek General Discussion, page-17191

Top Stories

Nanocap Middle Island Resources kicks off Barkly copper-gold drill run – a potential IOCG-style NT project

SKS Technologies wins US$90M award to supply power to international hyperscale data centre in Melbourne

Almonty locks in govt agreement for tungsten oxide plant in South Korea

Infini soars 50% as company reveals it could’ve just made uranium history – redefining what it means to be “high grade”

Nimy to raise $1.21M to explore 'newsy' WA targets

Week 27 Wrap: ASX hits all time high; CBA shares' two realities; US inflation hits 3% ahead of China plenum

Immutep reports strong response rate from immunotherapies treating carcinomas

Bitcoin investors need to know the risks

BHP dips as WA nickel suspended after A$6B hit; losses eased by US CPI and forewarning

ASX hits all time high out the gate on Friday trades following bullish US inflation data

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News